Circulating YKL-40 levels during human endotoxaemia

被引:57
作者
Johansen, JS
Krabbe, KS
Moller, K
Pedersen, BK
机构
[1] Univ Copenhagen, Herlev Hosp, Dept Rheumatol, DK-1168 Copenhagen, Denmark
[2] Univ Copenhagen, Rigshosp, Dept Infect Dis, DK-2100 Copenhagen, Denmark
[3] Univ Copenhagen, Rigshosp, Copenhagen Muscle Res Ctr, DK-2100 Copenhagen, Denmark
关键词
CHI3L1; endotoxin; HC-gp39; TNF-alpha; YKL-40;
D O I
10.1111/j.1365-2249.2005.02763.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
YKL-40 is secreted by macrophages and neutrophils and patients with bacterial infections have elevated circulating YKL-40. The aim was to evaluate changes in plasma YKL-40 (determined by enzyme-linked immunosorbent assay (ELISA) at 0, 2, 4, 8, 24 and 32 h) in eight healthy volunteers after injection with Esherichia coli endotoxin or saline. Plasma YKL-40 increased after endotoxin injection from 31 mu g/l (range 19-39 mu g/l) to a maximum of 159 mu g/l (61-552 mu g/l, P < 0.01) at 24 h. The finding that plasma YKL-40 increased after endotoxin injection compared with saline (P < 0.001) suggests that YKL-40 has a functional role in infections.
引用
收藏
页码:343 / 348
页数:6
相关论文
共 42 条
[1]   Antimicrobial activities of heparin-binding peptides [J].
Andersson, E ;
Rydengård, V ;
Sonesson, A ;
Mörgelin, M ;
Björck, L ;
Schmidtchen, A .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 2004, 271 (06) :1219-1226
[2]  
Baeten D, 2000, ARTHRITIS RHEUM, V43, P1233, DOI 10.1002/1529-0131(200006)43:6<1233::AID-ANR6>3.0.CO
[3]  
2-9
[4]   Strong induction of members of the chitinase family of proteins in atherosclerosis - Chitotriosidase and human cartilage gp-39 expressed in lesion macrophages [J].
Boot, RG ;
van Achterberg, TAE ;
van Aken, BE ;
Renkema, GH ;
Jacobs, MJHM ;
Aerts, JMFG ;
de Vries, CJM .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1999, 19 (03) :687-694
[5]   Endotoxemia stimulates skeletal muscle Na+-K+-ATPase and raises blood lactate under aerobic conditions in humans [J].
Bundgaard, H ;
Kjeldsen, K ;
Krabbe, KS ;
Van Hall, G ;
Simonsen, L ;
Qvist, J ;
Hansen, CM ;
Moller, K ;
Fonsmark, L ;
Madsen, PL ;
Pedersen, BK .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2003, 284 (03) :H1028-H1034
[6]   Serum YKL-40 and colorectal cancer [J].
Cintin, C ;
Johansen, JS ;
Christensen, IJ ;
Price, PA ;
Sorensen, S ;
Nielsen, HJ .
BRITISH JOURNAL OF CANCER, 1999, 79 (9-10) :1494-1499
[7]   Plasma YKL-40, as a prognostic tumor marker in recurrent ovarian cancer [J].
Dehn, H ;
Hogdall, EVS ;
Johansen, JS ;
Jorgensen, M ;
Price, PA ;
Engelholm, SAA ;
Hogdall, CK .
ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 2003, 82 (03) :287-293
[8]   Early detection and prognosis of ovarian cancer using serum YKL-40 [J].
Dupont, J ;
Tanwar, MK ;
Thaler, HT ;
Fleisher, M ;
Kauff, N ;
Hensley, ML ;
Sabbatini, P ;
Anderson, S ;
Aghajanian, C ;
Holland, EC ;
Spriggs, DR .
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (16) :3330-3339
[9]   Crystal structure and carbohydrate-binding properties of the human cartilage glycoprotein-39 [J].
Fusetti, F ;
Pijning, T ;
Kalk, KH ;
Bos, E ;
Dijkstra, BW .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (39) :37753-37760
[10]  
HAKALA BE, 1993, J BIOL CHEM, V268, P25803